The company said that the drug, listed on the FDA’s Current Drug Shortages list, is available in a pre-labeled, single patient, ready-to-use, tamper evident syringe admixture system, according to a company news release.
Read the PharMEDium news release about the availability of propofol.
Read more about propofol:
– BCBS of North Carolina Holds Strong on Use of Deep Sedation for Endoscopic Procedures Policy
– ASA Supports DEA Proposal to List Propofol on Schedule IV
– Impact of the Propofol Shortage on Anesthesiologists: Q&A With ASA President Alexander Hannenberg
